Phoenix Equity Partners

Phoenix Equity Partners is a prominent UK-based private equity firm that specializes in mid-market investments, with a significant focus on the healthcare and pharmaceutical services sectors. The firm partners with ambitious management teams to drive growth through strategic investment, operational improvements, and international expansion. Notable healthcare-related investments in their portfolio have included Sygnature Discovery, a leading drug discovery contract research organization, and Rayner, a global manufacturer of intraocular lenses for cataract surgery. Phoenix typically targets companies with enterprise values ranging from £50 million to £200 million, providing the capital and expertise necessary to scale businesses within the life sciences ecosystem. Their approach involves identifying high-growth niches and supporting buy-and-build strategies to create market leaders.